Drugs / Activated T lymphocyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01802138 | Feb 2013 → Jun 2016 | neuroblastoma | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Activated T lymphocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01802138 ↗ |
| Modality | Cell therapy | “Activated T-lymphocyte cell therapy” NCT01802138 ↗ |
| Route | Intravenous | “intravenous dripping of 200 ml (10\^9\~2\*10\^10 lymphocytes) for 1 hour.” NCT01802138 ↗ |